(Family Features) Many people don’t think much about whether their blood is clotting properly. However, when you have a bleeding disorder, a condition that affects the way your body controls clots, it ...

Medically reviewed by Cordelia Nwankwo, MD Key Takeaways Bleeding between periods can be caused by stress, poor nutrition, or ...

Let’s be honest: Periods, in general, aren’t exactly comfortable. If you’re one of the 10 million Americans who deal with heavy bleeding during your period, then you have all the more reason to ...

Many people have a bleeding disorder and don't know it, but the Western Pennsylvania Bleeding Disorders Foundation is working to help people recognize the signs and get support. The foundation helps ...

Megakaryocytes, which are derived from hematopoietic stem cell precursors in bone marrow, form and release platelets; these circulate in the blood for 8 to 10 days before they are removed by hepatic ...

Could your heavy flow be cause for concern? Sherri Ozawa, MSN, RN, tells The Post that serious blood loss during menstruation could be a symptom of von Willebrand disease, a blood disorder that ...

A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient evidence that a drug called pomalidomide, which is used to treat bone marrow ...

BioTek reMEDys has identified Bleeding Disorders Awareness Month (BDAM) as an opportunity to drive change, piggybacking on the national event to call for awareness of safe medication use in patients ...

Exterior of EMA, European Medicines Agency is seen in Amsterdam (Reuters) - The European Medicines Agency (EMA) has recommended the use of Pfizer's gene therapy for a rare bleeding disorder called ...

Pfizer Inc.’s gene therapy for a severe bleeding disorder met its goal in a pivotal late-stage trial, paving the way for the company to enter what’s proven to be a challenging market for drug ...

April 26 (Reuters) - The U.S. Food and Drug Administration approved Pfizer's (PFE.N), opens new tab gene therapy for hemophilia B on Friday, the second such therapy for the rare bleeding disorder that ...

A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that impacts more than 1 in ...